Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Gerald W. Prager's publication output changed over time?
ScholarIQpublication output · 2002–2025
Output grew0% over the shown period — from 1 works in 2002 to 1 in 2025.
1
1
1
1
1
1
1
1
2
1
2002200320072016201720192020202120232025
What are the most-cited papers on Gerald W. Prager?
ScholarIQmost cited works
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Thierry Conroy, Per Pfeiffer, Valérie Vilgrain, Ángela Lamarca, Thomas Seufferlein, Eileen M. O’Reilly, Thilo Hackert, Talia Golan, Gerald W. Prager, Karin Haustermans, Arndt Vogel, Michel Ducreux
Annals of Oncology. 2023551 CitationsOPEN ACCESS
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Vivek Subbiah, Ulrik Lassen, Elena Élez, Antoîne Italiano, Giuseppe Curigliano, Milind Javle, Filippo de Braud, Gerald W. Prager, Richard Greil, Alexander Stein, Angelica Fasolo, Jan H.M. Schellens, Patrick Y. Wen, Kert Viele, Aislyn Boran, Eduard Gasal, Paul Burgess, Palanichamy Ilankumaran, Zev A. Wainberg
The Lancet Oncology. 2020531 Citations
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Gerald W. Prager, Julien Taı̈eb, Marwan Fakih, Fortunato Ciardiello, Eric Van Cutsem, Elena Élez, Felipe Melo Cruz, Lucjan Wyrwicz, Daniil Stroyakovskiy, Zsuzsanna Pápai, Pierre-Guillaume Poureau, Gábor Liposits, Chiara Cremolini, Igor Bondarenko, Dominik Paul Modest, Karim A. Benhadji, Nadia Amellal, Catherine Leger, Loïck Vidot, Josep Tabernero
New England Journal of Medicine. 2023445 CitationsOPEN ACCESS
uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view
Judit Mihaly, Gerald W. Prager, Bernd R. Binder
S206235894. 2007232 Citations
Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles
Bernd R. Binder, Günter Christ, Флориан Грубер, Nelly Grubic, Peter Hufnagl, Michael Krebs, Judit Mihaly, Gerald W. Prager
S88977973. 2002226 Citations
Related on ScholarIQ
Medical University of Vienna
Institution
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Paper
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Paper
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Paper
uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view
Paper
Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles
Paper